NCT00124605View on ClinicalTrials.gov

Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2009

Conditions
Refractory Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pamidronate disodium

Given IV

DRUG

arsenic trioxide

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00124605 - Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma | Biotech Hunter | Biotech Hunter